Pere Santamaria, PhD, MD

Founder & CSO

Dr. Santamaria holds both an MD and PhD from University of Barcelona, Spain, and completed post-doctoral studies at the University of Minnesota prior to joining the Faculty of Medicine at the University of Calgary as Assistant Professor in 1992. He is an internationally recognized immunologist specialized in T1D and Julia McFarlane/Diabetes Canada Professor of the Cumming School of Medicine at the University of Calgary. Dr. Santamaria has published extensively in peer-reviewed journals, demonstrating that Navacims can reprogram disease- or tissue-specific cells to enhance the regulatory functioning of the immune system in preclinical in vivo models of a variety of autoimmune diseases. Pere has received several honors and awards, including the Alberta Heritage Foundation for Medical Research Senior Scholar, Scientist and Senior Scientist awards, the Canadian Diabetes Association Young Investigator award and the Juvenile Diabetes Research Foundation Scholar award and most recently the winner of the 2013 ASTech Foundation’s Outstanding Leadership in Alberta Technology award. He has published over 150 publications, many in high-impact journals, and he is a regularly invited speaker at national and international forums. He sits on the editorial board of a number of journals and numerous national and international grant review panels.